#Surgical Microscopes Market Report

[industrynewsupdates]

Growth of Surgical Microscopes Market: Key Factors Driving Demand

The global surgical microscopes market was valued at USD 1.4 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 11.56% from 2024 to 2030. The growth of the market is primarily driven by several key factors, including the increasing number of surgical procedures, the rising demand for greater precision in surgeries, and the introduction of emerging technologies. These technologies include innovations such as wide-angle illumination, red reflex illumination, and Augmented Reality (AR) microscopy, all of which are enhancing the capabilities of surgical microscopes and making them indispensable tools in modern medical practices.

Surgical microscopes have become critical for performing minimally invasive procedures across a wide range of medical disciplines. They are particularly vital in specialized fields such as neurosurgery, ophthalmic surgery, dental surgery, otorhinolaryngology (ENT), and cosmetic surgery. These procedures require the utmost precision and clarity, which surgical microscopes provide by offering magnified, high-definition views of the surgical site. As surgical procedures become more complex and require higher accuracy, the role of surgical microscopes in ensuring successful outcomes has become even more prominent.

Technological advancements in the design and functionality of surgical microscopes have also significantly contributed to the market's growth. For example, the digitalization of surgical microscopes has revolutionized their quality and effectiveness. Digital technologies allow for the integration of high-resolution cameras, improved lighting systems, and enhanced visual clarity, which aid in precise surgical execution. Moreover, digital platforms enable better documentation, sharing of surgical footage, and remote consultation, further streamlining the surgical process.

In addition to technological improvements, manufacturers are increasingly designing integrated surgical systems that help to optimize the workflow of surgical practices, particularly in hospitals and outpatient surgical centers. These integrated systems combine the surgical microscope with other medical equipment, such as endoscopes and laser systems, creating a more efficient and effective operating environment. Customization options are also on the rise, with companies offering specialized surgical microscopes tailored to the specific needs of different medical specialties. For example, there are now ophthalmic microscopes for eye surgeries, ENT microscopes for ear, nose, and throat procedures, dental microscopes for dental surgeries, and neurosurgical microscopes for brain and spinal surgeries.

Gather more insights about the market drivers, restrains and growth of the Surgical Microscopes Market

Regional Insights

North America led the global surgical microscopes market with a substantial market share of 39.25% in 2023. The region's dominance can be attributed to several factors, including a supportive reimbursement framework for medical treatments, which helps make advanced surgical procedures more accessible to patients. Additionally, North America's healthcare infrastructure is highly sophisticated, with hospitals and surgical centers equipped with cutting-edge medical technology. The region is home to a large number of skilled neurosurgeons and cosmetic surgeons who are adept at utilizing the latest surgical tools, including advanced surgical microscopes. These professionals contribute to the region's strong performance in the surgical microscopes market.

Furthermore, North America faces a higher prevalence of ophthalmic and neurologic disorders, such as cataracts, glaucoma, and various neurological conditions. This higher incidence rate further drives the demand for specialized surgeries and, consequently, the need for precision tools like surgical microscopes. These factors together have played a significant role in boosting the market growth in North America, reinforcing its leading position in the global market.

Asia Pacific, on the other hand, is expected to register the fastest CAGR in the surgical microscopes market during the forecast period. This growth is primarily driven by the rising incidence of ophthalmic disorders across the region. The increasing number of people requiring eye surgeries such as cataract removal and refractive surgeries is a major contributor to the demand for surgical microscopes. Additionally, medical tourism is rapidly growing in several Asia-Pacific countries, as patients from developed nations seek more affordable yet high-quality medical procedures. This influx of international patients has spurred the need for modern medical technologies, including surgical microscopes, in hospitals and surgical centers across the region.

The expansion of inpatient and outpatient surgeries in Asia Pacific is also driving the demand for surgical microscopes, as more procedures require the precision that these devices provide. Furthermore, favorable government policies aimed at improving healthcare systems and the rapid economic development of several countries in the region are expected to further propel market growth. These policies include investments in healthcare infrastructure, as well as initiatives to enhance medical education and training for healthcare professionals.

Among the countries in the Asia Pacific, India is anticipated to witness the fastest CAGR during the forecast period. The surge in minimally invasive surgeries—which require precise instruments like surgical microscopes—is one of the key drivers of this growth. India's expanding healthcare sector is complemented by the presence of both multinational and local manufacturers who are introducing affordable and advanced surgical microscope solutions. The average cost of operating a surgical microscope in India is estimated to be between USD 3,000 and 5,000, making it a more accessible option for healthcare facilities in the country. This affordability, combined with the increasing demand for high-precision surgeries, is expected to contribute significantly to India's market expansion.

Browse through Grand View Research's  Medical Devices Industry Research Reports.

• The global molecular diagnostics market size was estimated at USD 15.20 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2030.

• The global polymerase chain reaction market size was valued at USD 36.84 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of -9.30% from 2023 to 2030.

Key Companies & Market Share Insights

Key players in the surgical microscopes market are adopting various strategic initiatives to strengthen their position in the industry. These strategies include new product launches, collaborations with hospitals and surgical centers for product installation and implementation, and mergers and acquisitions to expand product portfolios and enhance market presence.

For example, many companies are working closely with hospitals and outpatient surgical centers to provide tailored solutions for different surgical specialties, such as neurosurgery, ophthalmic surgery, and ENT procedures. Additionally, collaborative partnerships with healthcare institutions allow companies to ensure that their products meet the highest standards in terms of performance and precision. This approach helps companies tap into specific niches in the market, addressing the unique needs of various medical specialties.

By merging with or acquiring other companies, leading players in the surgical microscopes market can expand their product offerings, integrate innovative technologies, and gain access to new regional markets, which further enhances their competitive edge. These strategies allow companies to stay at the forefront of technological advancements and meet the increasing demand for advanced surgical solutions worldwide.

Key Surgical Microscopes Companies:

• Carl Zeiss Meditec AG

• Leica Microsystems

• Olympus Corporation

• haag-streit.com

• Synaptive Medical

• Alcon, Inc.

• TOPCON CORORATION

• Takagi Seiko Co., Ltd.

• ARI Medical Technology Co., Ltd.

• Chammed Co., Ltd.

• Seiler Instrument, Inc.

Order a free sample PDF of the Surgical Microscopes Market Intelligence Study, published by Grand View Research.

[lovelypol]

Ophthalmology Devices Market Projected to Grow to $110 Billion by 2033 with a 6.3% CAGR

Ophthalmology Devices Market : Ophthalmology devices are revolutionizing the way we diagnose, treat, and manage eye conditions. From advanced diagnostic tools like OCT (Optical Coherence Tomography) and slit-lamp microscopes to cutting-edge treatments such as laser eye surgery equipment and retinal implants, these innovations are improving vision care outcomes worldwide. With the rise of AI-powered diagnostics and minimally invasive surgical technologies, ophthalmology devices are enabling faster, more accurate, and less painful procedures for patients. These advancements not only improve vision but also enhance the quality of life for individuals suffering from eye diseases like cataracts, glaucoma, and macular degeneration.

To Request Sample Report : https://www.globalinsightservices.com/request-sample/?id=GIS32435 &utm_source=SnehaPatil&utm_medium=Article

The growing global prevalence of eye conditions, along with the aging population, is driving the demand for more sophisticated ophthalmology devices. From telemedicine tools that allow remote monitoring to surgical robots designed for precision, the future of ophthalmology is becoming increasingly digital and patient-centered. These devices are making eye care more accessible and efficient, transforming how we approach treatment, rehabilitation, and prevention of vision impairment. As technology continues to evolve, the potential for even more groundbreaking solutions in vision care is limitless.

#Ophthalmology #VisionCare #EyeHealth #MedicalDevices #EyeSurgery #AIInHealthcare #VisionTechnology #RetinalHealth #LaserSurgery #GlaucomaTreatment #CataractSurgery #OCTImaging #HealthcareInnovation #MedicalBreakthroughs #FutureOfMedicine

[watsonmac]

https://introspectivemarketresearch.com/reports/3d-surgical-microscope-systems-market/

[creativeera]

Understanding How Nanorobotics is Revolutionizing Our Future

Nanorobotics refers to the specialized branch of nanotechnology that deals with designing and building nanorobots; tiny robots or machines that have components measuring from 1 to 100 nanometers and can be programmed to perform specific tasks at the microscopic level. Nanorobots have the potential to revolutionize various industries by allowing tasks to be performed at the molecular level with unprecedented precision and control. Some of the key areas where nanorobotics is having a transformative impact include biomedical sciences, manufacturing, environmental remediation and more. Biomedical Applications One of the most promising applications of nanorobots is in the field of biomedical sciences and healthcare. Biomedical nanorobots could be miniaturized surgical machines that can be injected into the human body to repair damage at the cellular level, destroy cancer cells or target other injuries and diseases. They may even be able to augment cell and tissue regeneration. Researchers are working on developing blood nanobots that are smaller than red blood cells and can circulate through the body detecting problems and releasing medications only where needed. This would make treatments more targeted and reduce side effects. Another exciting possibility is assembling nanoscale medical devices inside the body from smaller components using nanorobots to perform complex surgeries or even augment certain body functions without invasive procedures. Targeted Drug Delivery By precisely delivering drugs, nutrients or other therapeutics only to diseased cells and tissues, nanorobots could revolutionize drug formulation and delivery. They could improve current treatments by encasing medicines in nanoparticles which are then guided by Nanorobotics to only affected areas via navigation techniques like magnetotaxis. This would maximize therapeutic benefits while minimizing unwanted side effects. For conditions like cancer, nanorobots may one day be used to transport cytotoxic drugs directly into tumors, killing them more effectively while sparing healthy cells. Chronic diseases requiring lifelong medication like diabetes may also benefit from nanorobots programmed to automatically release insulin only when blood sugar levels rise beyond a set point. Environmental Remediation Environmental pollution poses a serious threat and cleaning up toxic waste sites or oil spills manually is a complex challenge. Nanorobots have the potential to selectively identify and remove toxins from the environment autonomously. They could be deployed to absorb or break down pollutants like heavy metals or hydrocarbons at a molecular level. Teams of coordinated nanorobots may remediate sites more efficiently one day by sensing hazards, communicating data and self-assembling into larger structures as needed for pollution digestion or containment. Some researchers are even developing photoactive nanorobot catalysts that could help break down plastic waste using sunlight. Such applications may transform current waste management and decontamination methods.

Get more insights on Nanorobotics

Discover the Report for More Insights, Tailored to Your Language.

French

German

Italian

Russian

Japanese

Chinese

Korean

Portuguese

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

[credenceresearchdotblog]

The Bio-MEMS Market is projected to grow from USD 7,901.23 million in 2023 to an estimated USD 21,045.95 million by 2032, with a compound annual growth rate (CAGR) of 11.50% from 2024 to 2032.The Bio-Microelectromechanical Systems (Bio-MEMS) market has emerged as a dynamic field of innovation at the intersection of biology and engineering. Bio-MEMS refers to the integration of microelectromechanical systems (MEMS) technology with biological elements to create devices that can manipulate, monitor, or interact with biological systems on a microscopic scale. These systems are revolutionizing the medical field by enabling more efficient diagnosis, targeted therapies, and advancements in personalized medicine. As technological advancements continue to drive the market forward, Bio-MEMS has become pivotal in reshaping modern healthcare.

Browse the full report at https://www.credenceresearch.com/report/bio-mems-market

Market Overview

The Bio-MEMS market has experienced significant growth in recent years, fueled by advances in microfabrication technology, increased demand for point-of-care diagnostics, and the rise of personalized medicine. The global Bio-MEMS market was valued at approximately $2.5 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 15-20% from 2023 to 2030. This rapid growth is being driven by an array of applications including drug delivery, biosensors, diagnostic tools, and minimally invasive surgical tools.

The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders has spurred the demand for more precise and cost-effective diagnostic tools, which Bio-MEMS technology is well-equipped to provide. Additionally, the rise of wearable medical devices and home healthcare systems has broadened the scope of Bio-MEMS applications beyond traditional healthcare settings.

Key Drivers of Growth

1. Miniaturization of Medical Devices One of the key advantages of Bio-MEMS is its ability to miniaturize complex diagnostic and therapeutic devices, making them more portable, less invasive, and more efficient. This trend toward miniaturization allows for the development of lab-on-a-chip (LOC) systems, which can perform multiple laboratory functions on a single chip the size of a credit card. LOC devices, powered by Bio-MEMS, are becoming essential tools for point-of-care diagnostics, allowing patients to receive quick and accurate test results at home or in remote locations.

2. Growing Demand for Personalized Medicine As healthcare continues to shift toward more individualized treatments, the demand for personalized medicine has been on the rise. Bio-MEMS devices offer the ability to tailor diagnostic and therapeutic interventions to a patient’s specific needs. By providing real-time monitoring and data collection, these systems help medical professionals design more effective treatment plans based on the unique genetic, biochemical, and environmental factors affecting a patient. For instance, biosensors integrated with Bio-MEMS technology can detect specific biomarkers in the blood, enabling earlier diagnosis and more targeted treatments for diseases like cancer.

 3. Advancements in Microfabrication Technology Innovations in microfabrication and nanotechnology have been instrumental in advancing Bio-MEMS technology. The ability to create highly sensitive and precise devices on a microscopic scale has opened the door to new applications in drug delivery systems, implantable devices, and tissue engineering. For example, implantable Bio-MEMS devices can deliver drugs in controlled doses directly to affected areas, reducing side effects and improving therapeutic outcomes. These innovations are pushing the boundaries of what is possible in modern healthcare, with new devices being developed for a wide range of medical applications.

Key Applications

1. Biosensors and Diagnostics Biosensors are one of the most prominent applications of Bio-MEMS technology. These devices can detect the presence of specific biological molecules, such as glucose, proteins, or DNA, and convert this information into electrical signals that can be easily interpreted. Bio-MEMS biosensors are used in glucose monitoring for diabetic patients, detecting pathogens in blood samples, and measuring biomarkers for cancer diagnosis. The ability to detect diseases early, at a molecular level, has made these sensors indispensable in clinical diagnostics.

2. Drug Delivery Systems Bio-MEMS devices have transformed drug delivery by offering precision-controlled release mechanisms. Implantable Bio-MEMS systems can release therapeutic agents in response to specific stimuli, such as pH levels or temperature changes in the body, improving the efficacy of the treatment while minimizing side effects. This is especially beneficial in the treatment of chronic diseases, where continuous, targeted drug delivery is essential.

3. Minimally Invasive Surgery Bio-MEMS devices are also contributing to the development of minimally invasive surgical tools. These tools allow surgeons to perform complex procedures with minimal damage to surrounding tissues, reducing recovery times and improving patient outcomes. Micro-scale devices such as catheters with embedded sensors or drug-eluting stents have become common in cardiovascular procedures, where precision is paramount.

Challenges and Future Trends

While the Bio-MEMS market is on a growth trajectory, there are challenges to its widespread adoption. One major challenge is the high cost of developing and manufacturing Bio-MEMS devices, which can limit their accessibility. Regulatory hurdles are another obstacle, as these devices must undergo rigorous testing to ensure their safety and efficacy in clinical settings.

Despite these challenges, the future of Bio-MEMS looks promising. As microfabrication techniques become more cost-effective and regulatory frameworks evolve, we can expect to see a surge in the development of new Bio-MEMS-based applications. The integration of artificial intelligence (AI) and machine learning (ML) with Bio-MEMS technology is another trend to watch, as it has the potential to enhance diagnostic accuracy and treatment efficacy.

Key players

Becton Dickinson

Abbott Laboratories

Boston Scientific

PerkinElmer

Medtronic

Baxter International

Teledyne DALSA Inc.

Segments

Based on Type

Gyroscopes

Accelerometers

Others

Based on Application

Neural Implants

Bionics

ENT Implants

Cardio-MEMS

Others

Based on Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/bio-mems-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[pranalip]

Histopathology Services Market Global Industry Trends and Market Outlook 2024-2033 | Global Insight Services

Global Insight Services has recently updated its global market reports, now including the latest data for 2024 and projections through 2033.

The global Histopathology Services Market was valued at USD 22.8 Billion in 2022 and it is anticipated to grow up to USD 38.4 Billion by 2032, at a CAGR of 5.4% during the forecast period.

Histopathology services are used in the examination of biological tissues for the diagnosis of diseases. The procedure includes microscopic examination of tissues. With the help of imaging techniques biopsy tissues can now be obtained from certain inaccessible sites such as pancreas and the peritoneum.

To Know More@ https://www.globalinsightservices.com/reports/histopathology-services-market/?utm_id=Pranalip

Market Trends and Drivers

Factors such as rising demand for biologics and increasing prevalence of chronic diseases are driving the histopathology services market. However, limitations associated with histopathology and immunohistochemistry are expected to restrict the market growth to a certain extent during the forecast period. Further, increasing government support to advance the smart technologies in preliminary diagnosis has led to robust development of histopathology services. Additionally, technology has played crucial in minimizing the complication of the manual process and advanced the existing histopathology technologies. Other factors like increasing public investments in advancing the histopathology services have fuelled the growth of the market. On the other hand, limitations associated with histopathology and immunohistochemistry is expected to restrain the overall market growth to a certain extent during the forecast period.

Request Sample@ https://www.globalinsightservices.com/request-sample/GIS10504/?utm_id=Pranalip

Research Objectives

Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region

Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling

Identify factors influencing market growth and challenges, opportunities, drivers and restraints

Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates

Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities

Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market

To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.

Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives

Request Customization@ https://www.globalinsightservices.com/request-customization/GIS10504/?utm_id=Pranalip

Global Histopathology Services Market Segmentation

By Type

Surgical Specimen

Breast Biopsy

Lung Biopsy

Renal Biopsy

Gastrointestinal Biopsy

Pancreatic Biopsy

Skin Tissue Biopsy

Testicular Biopsy

Others

By End-user

Diagnostic Laboratories and Reference Laboratories

Research Institutes

Others

Major Players in the Global Histopathology Services Market

The key players in the market are Sonic Healthcare Limited; Laboratory Corporation of America Holdings; Acculabs Diagnostics UK Ltd; TPL Path Labs; UNILABS; Cureline Global Translational CRO; Targos; Cellular Pathology Services; Experimental Pathology Laboratories Inc (EPL); and CHARLES RIVER LABORATORIES, INC.. among others.

Buy your copy here@ https://www.globalinsightservices.com/checkout/single_user/GIS10504/?utm_id=Pranalip

Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

lobal Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

[delveinsight12]

Central Nervous System Lymphoma Market to Witness Growth by 2032 | Companies- Novartis, Prelude Therapeutics, Kite, Celgene

DelveInsight's "Central Nervous System Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Central Nervous System Lymphoma, historical and forecasted epidemiology as well as the Central Nervous System Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Central Nervous System Lymphoma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Central Nervous System Lymphoma market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Central Nervous System Lymphoma treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Central Nervous System Lymphoma market.

Central Nervous System Lymphoma Overview

Central nervous system lymphoma is a rare non-Hodgkin lymphoma in which malignant (cancer) cells from lymph tissue form in the brain and/or spinal cord (primary CNS) or spread from other parts of the body to the brain and/or spinal cord (secondary CNS). Central nervous system lymphoma is more common in men than women. the exact causes of CNS lymphoma are not known, there are several factors that may increase a person's risk for developing the disease, such as having a compromised immune system due to acquired immunodeficiency syndrome (AIDS), other disorders of the immune system, or chronic immunosuppression (a reduced function of the immune system) as a result of organ transplantation. To diagnose Central Nervous System lymphoma different tests are used to examine the eyes, brain and spinal cord. Physical exam and history, neurological exam to check mental status, coordination, ability to walk normally and how well the muscles, senses and reflexes work, slit-lamp eye exam - this test uses a special microscope with a bright, narrow slit of light to check the outside and inside of the eye. Vitrectomy - A surgical procedure in which some of the vitreous humor (the gel-like fluid inside the eyeball) is removed and examined under a microscope to check for cancer cells. Chest x-ray and CT scans of the chest and abdomen. MRI scans of the brain and spinal cord. There is no standard treatment for Central Nervous System lymphoma. Methotrexate-based combinations that include rituximab (Rituxan) have been the most successful for Central Nervous System lymphoma patients. Methotrexate is usually given at high doses and requires that the patient be hospitalized while giving the chemotherapy.

Learn more about Central Nervous System Lymphoma, treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ Central Nervous System Lymphoma Market Outlook 2032

Central Nervous System Lymphoma Market 

The Central Nervous System Lymphoma market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Central Nervous System Lymphoma market trends by analyzing the impact of current Central Nervous System Lymphoma therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Central Nervous System Lymphoma market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Central Nervous System Lymphoma market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Central Nervous System Lymphoma market in 7MM is expected to witness a major change in the study period 2019-2032.

Request a sample and discover more about the report offerings at: https://www.delveinsight.com/sample-request/central-nervous-system-lymphoma-market

Central Nervous System Lymphoma Epidemiology 

The Central Nervous System Lymphoma epidemiology section provides insights into the historical and current Central Nervous System Lymphoma patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Central Nervous System Lymphoma market report also provides the diagnosed patient pool, trends, and assumptions. 

Click here and explore more about Central Nervous System Lymphoma Epidemiology

Central Nervous System Lymphoma Drugs Uptake

This section focuses on the uptake rate of the potential Central Nervous System Lymphoma drugs recently launched in the Central Nervous System Lymphoma market or expected to be launched in 2019-2032. The analysis covers the Central Nervous System Lymphoma market uptake by drugs, patient uptake by therapies, and sales of each drug.   

Central Nervous System Lymphoma Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Central Nervous System Lymphoma market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Key Central Nervous System Lymphoma Companies

• Shandong New Time Pharmaceutical

• PIQUR Therapeutics

• Ono Pharmaceutical

• Janssen, LP

• Kazia Therapeutics

• Beijing InnoCare Pharma Tech

• Celltrion

• Bristol Myers Squibb

• AstraZeneca

• Novartis

• Prelude Therapeutics

• Kite, A Gilead Company

• Celgene

Central Nervous System Lymphoma Pipeline Development Activities

The Central Nervous System Lymphoma report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Central Nervous System Lymphoma key players involved in developing targeted therapeutics.

Request for a sample report to understand more about the Central Nervous System Lymphoma pipeline development activities at: Central Nervous System Lymphoma Therapy Assessment

Central Nervous System Lymphoma Therapeutics Assessment

Major key companies are working proactively in the Central Nervous System Lymphoma Therapeutics market to develop novel therapies which will drive the Central Nervous System Lymphoma treatment markets in the upcoming years.

Get the Detailed TOC of the Central Nervous System Lymphoma Market report here: Central Nervous System Lymphoma Market

[pranalipawarshinde]

Histopathology Services Market Trends and Forecast 2024-2033

“Global Insight Services offers unparalleled market intelligence and strategic consulting services to businesses worldwide. Our expertise spans across various industries, including healthcare, technology, and consumer goods, providing comprehensive analysis and actionable insights. By leveraging advanced data analytics and in-depth market research, we empower our clients to make informed decisions, identify growth opportunities, and stay ahead of the competition”.

The global Histopathology Services Market was valued at USD 22.8 Billion in 2022 and it is anticipated to grow up to USD 38.4 Billion by 2032, at a CAGR of 5.4% during the forecast period.

View The Full Report Here –https://www.globalinsightservices.com/reports/histopathology-services-market

Histopathology services are used in the examination of biological tissues for the diagnosis of diseases. The procedure includes microscopic examination of tissues. With the help of imaging techniques biopsy tissues can now be obtained from certain inaccessible sites such as pancreas and the peritoneum.

Market Trends and Drivers

Factors such as rising demand for biologics and increasing prevalence of chronic diseases are driving the histopathology services market. However, limitations associated with histopathology and immunohistochemistry are expected to restrict the market growth to a certain extent during the forecast period. Further, increasing government support to advance the smart technologies in preliminary diagnosis has led to robust development of histopathology services. Additionally, technology has played crucial in minimizing the complication of the manual process and advanced the existing histopathology technologies. Other factors like increasing public investments in advancing the histopathology services have fuelled the growth of the market. On the other hand, limitations associated with histopathology and immunohistochemistry is expected to restrain the overall market growth to a certain extent during the forecast period.

Market Restraints and Challenges

The disadvantages of histology and histological staining include: Preparation of the slides using the paraffin technique can be time-consuming; frozen slides are faster to prepare, but this can affect the resolution, especially when using light microscopy. However, limitations associated with histopathology and immunohistochemistry are expected to restrict the market growth to a certain extent during the forecast period. Subspecialisation in the diagnostic surgical pathology service and cytology; frozen sections; the autopsy; multidisciplinary team meetings; ancillary techniques; the pathology report and some other administrative duties.

Unlock Growth Potential in Your Industry – Get Your Sample Report Now-https://www.globalinsightservices.com/request-sample/GIS10504

Global Histopathology Services Market Segmentation

By Type

Surgical Specimen

Breast Biopsy

Lung Biopsy

Renal Biopsy

Gastrointestinal Biopsy

Pancreatic Biopsy

Skin Tissue Biopsy

Testicular Biopsy

Others

By End-user

Diagnostic Laboratories and Reference Laboratories

Research Institutes

Others

Major Players in the Global Histopathology Services Market

The key players in the market are Sonic Healthcare Limited; Laboratory Corporation of America Holdings; Acculabs Diagnostics UK Ltd; TPL Path Labs; UNILABS; Cureline Global Translational CRO; Targos; Cellular Pathology Services; Experimental Pathology Laboratories Inc (EPL); and CHARLES RIVER LABORATORIES, INC.. among others.

COVID-19 Impact:

At present, COVID-19 has made a major impact on the healthcare industry. Since the outbreak reached the U.S. in January 2020, hospitals, pharmacies, and other facilities have had to address challenges at a magnitude that had never been seen before. Moreover, according to a recent survey by Medscape in April 2020, substantial disruption have been witnessed in routine cancer care that includes tests for screening and diagnosis in suspected cases to their treatment as a result of the COVID-19 pandemic. The rapid increase in the number of infected patients in the US and Canada is likely to hamper the growth of histopathology services market and result in slowing down the market growth in the near future. Currently, many countries are now undergoing lockdown relaxations, and most hospitals have resumed elective surgeries. As a result, the number of diagnostic tests conducted is now increasing. Owing to the factors mentioned above, the overall growth rate of the anatomic pathology market is less when compared to the previous year.

Buy Now@https://www.globalinsightservices.com/checkout/single_user/GIS10504

Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

[deshpandeisha]

Understanding Olfactory Neuroblastoma: A Rare but Treatable Cancer

Olfactory neuroblastoma, also known as esthesioneuroblastoma, is a rare type of cancer that originates in the olfactory nerve, which is responsible for our sense of smell. This malignancy typically arises in the upper part of the nasal cavity and can extend to adjacent areas, including the sinuses and the base of the skull.

sample Report@ https://www.emergenresearch.com/request-sample/1544

Symptoms

The symptoms of olfactory neuroblastoma can often be mistaken for less serious conditions, making early diagnosis challenging. Common symptoms include:

Nasal Congestion: Persistent nasal blockage not relieved by typical decongestants.

Nosebleeds: Frequent and unexplained nosebleeds.

Loss of Smell: A gradual or sudden loss of the sense of smell (anosmia).

Facial Pain or Swelling: Pain or swelling in the face, often around the eyes.

Visual Disturbances: Double vision or vision loss if the tumor extends to the eye area.

Headaches: Persistent headaches that do not respond to usual treatments.

Diagnosis

Diagnosing olfactory neuroblastoma involves a combination of clinical evaluation, imaging studies, and biopsy:

Nasal Endoscopy: A thin, flexible tube with a camera is inserted through the nose to visualize the tumor.

Imaging Studies: CT scans and MRIs help determine the size and extent of the tumor and its impact on surrounding structures.

Biopsy: A tissue sample is taken and examined under a microscope to confirm the diagnosis.

Read More@ https://www.emergenresearch.com/industry-report/olfactory-neuroblastoma-market

Treatment

Treatment for olfactory neuroblastoma is multidisciplinary and often includes:

Surgery: The primary treatment for olfactory neuroblastoma is surgical removal of the tumor. Endoscopic surgery is often used to minimize damage to surrounding tissues.

Radiation Therapy: Post-surgery radiation therapy helps eliminate any remaining cancer cells and reduce the risk of recurrence.

Chemotherapy: In some cases, chemotherapy may be used, especially if the cancer has spread beyond the nasal cavity.

Prognosis

The prognosis for olfactory neuroblastoma varies depending on the stage of the cancer at diagnosis and the effectiveness of treatment. Early-stage tumors that are completely removed have a better prognosis. Regular follow-up is essential to monitor for any signs of recurrence.

Research and Advances

Ongoing research is focused on better understanding the genetic and molecular basis of olfactory neuroblastoma, which may lead to more targeted and effective treatments in the future. Advances in imaging techniques and minimally invasive surgical methods continue to improve outcomes for patients with this rare cancer.

[bhushans]

Meeting the Needs of a Growing Population: The Evolving Global Veterinary Procedure Lights Market

The veterinary procedure lights market  is predicted to expand from USD 303.8 million in 2023 to an estimated USD 463.9 million by 2033, indicating a strong development trajectory. Over the course of the projection period, this growth translates into a noteworthy compound annual growth rate (CAGR) of 4.3%.

Veterinary process lights are vital equipment found in hospitals and clinics for veterinary care, since they offer vital lighting for a range of surgical and medical operations. These lights are essential for maintaining accuracy, safety, and efficiency in veterinary care, allowing vets to carry out difficult procedures with better vision and precision.

A veterinary procedure light market study highlights the rapidly emerging fields of innovation and technology, as well as the significance of surgical lighting for operational repositioning. Usually, these process lights are utilized for minimally invasive operations that require a fair amount of accuracy. Furthermore, the market for veterinary procedure lights is growing thanks to innovative technologies and the most recent advancements in light technology.

Request Your Detailed Report Sample With Your Work Email: https://www.futuremarketinsights.com/reports/sample/rep-gb-5148

The increasing pet humanization, particularly among pet owners who have begun to treat their animals as members of their own families, is the cause of the expanding number of veterinary clinics and healthcare facilities. This also includes the monthly examinations, diagnosis, and care provided by veterinarians. For the duration of the forecast period, this is anticipated to raise demand for veterinary procedure lights.

Better veterinary equipment is becoming more and more necessary due to the strong trend of pet adoption in Western nations. The attempt to promote these growth opportunities for the veterinary process lights industry is supported by the government. Furthermore, as a result of these factors, the veterinary procedure market is expected to grow and prosper as these devices are integrated with artificial intelligence, the Internet of Things (IoT), and nanotechnology.

Key Takeaways:

The global veterinary procedure lights market is poised to surge from US$303.8 million in 2023 to US$463.9 million by 2033, reflecting a steady CAGR of 4.3%.

Rising technological advancements, coupled with the crucial role of surgical lighting in precise veterinary procedures, are fueling market growth.

The advent of efficient LED lights across operating room, exam, and handheld categories further bolsters market prospects.

How Key Players are Contributing to the Veterinary Procedure Lights Market?

There are many notable players in the highly fragmented veterinary procedure lighting market. In terms of market share, a small number of very large companies currently control the sector. Sunnex Group, ACEM S.p.A., MDS, Midmark Corporation, Medical Illumination, and Suburban Surgical Co., Inc. Incorporated are some of the industry leaders.

Recent Developments:

Atena Lux attended the Arab Health 2022 conference, which was held in Dubai.

Dispomed Ltd. announced their alliance with ARVS in April 2022. The focus of this collaboration will be on offering the best medical equipment and tailored technical service to veterinary clinics.

Key Companies Profiled:

Sunnex Group

Dispomed ltd

ACEM S.p.A

Philips Lighting Holding B.V

HAEBERLE Midmark Corporation

Atena Lux

Avante Health Solutions Company

MDS Incorporated.

Suburban surgical Co Inc

Market Segmentation:

By Product Type:

Examination lights

Surgery Lights

Frontal Binocular Microscope and Headlights

By Modality:

Floor Stand

Wall Mount

Single head Ceiling Mount

Double-head Ceiling Mount

By End User:

Veterinary Hospitals

Veterinary Clinics

Veterinary Diagnostic Centers

Others

By Region:

North America

Latin America

Europe

South Asia & Pacific

East Asia

The Middle East & Africa (MEA)

[gis56]

Molecular Diagnostics: A New Frontier in Anatomic Pathology

Anatomic pathology serves as the cornerstone of diagnostic medicine, providing invaluable insights into the nature and progression of diseases through the examination of tissues and cells under a microscope.

This specialized field encompasses a wide range of techniques and methodologies aimed at identifying abnormalities, characterizing diseases, and guiding treatment decisions. From biopsies to surgical specimens, anatomic pathologists play a crucial role in interpreting the microscopic features of tissues, helping clinicians make accurate diagnoses and develop personalized treatment plans. Advances in technology, such as digital pathology and molecular diagnostics, have further expanded the capabilities of anatomic pathology, enabling more precise and comprehensive analysis of specimens. With digital pathology, images of tissue samples can be digitized and analyzed remotely, facilitating collaboration among pathologists and enhancing diagnostic accuracy. Molecular diagnostics, on the other hand, allow for the detection of specific genetic mutations and biomarkers associated with various diseases, paving the way for targeted therapies and personalized medicine. As the field continues to evolve, anatomic pathology remains at the forefront of medical innovation, driving advancements in diagnosis, prognostication, and therapeutic decision-making, ultimately improving patient outcomes and shaping the future of healthcare.#AnatomicPathology #DiagnosticMedicine #PrecisionMedicine #DigitalPathology #MolecularDiagnostics #HealthcareInnovation #MedicalTechnology #Pathology #DiseaseDiagnosis #PersonalizedMedicine #HealthcareAdvancements #MedicalResearch #HealthcareQuality #DiseaseCharacterization #DiagnosticAccuracy

[trendingreportz]

Electric Motor Market - Forecast(2024 - 2030)

 Electric Motor Market Overview

Electric Motor Market Size is forecast to reach $169 billion by 2030, at a CAGR of 5.6% during 2024-2030. The increase in global electricity consumption and the use of electrical equipment and machines in different industries and the renewables sector are major factors driving the growth in the electric motor market during the forecast period. An increase in awareness of green vehicles among customers has been a key factor leading the market. Besides this, a rising number of government incentives to encourage sales of green vehicles for safeguarding the environment from carbon emissions is analysed to drive the market. The growing interest in sustainable transportation has driven the demand for electric vehicles. Electric motors play a crucial role in powering EVs, and advancements in motor technology contribute to increased efficiency and range. The industrial sector is witnessing the integration of electric motors with the Internet of Things (IoT) and Industry 4.0 technologies. This integration allows for real-time monitoring, predictive maintenance, and improved efficiency in industrial processes.

Smart motor technologies, incorporating features like connectivity, sensors, and advanced control systems, are becoming more prevalent. These innovations contribute to better performance, remote monitoring, and enhanced automation in various applications. Developments in motor control systems, including advanced algorithms and power electronics, contribute to improved motor performance, reduced energy losses, and enhanced control precision. There is an increasing emphasis on developing more energy-efficient electric motors to meet sustainability goals and reduce energy consumption. Regulations and standards promoting energy efficiency also influence the design and manufacturing of electric motors. Additionally, Electric motors have been observing several advancements in technology over the past few years, owing to which its demand is set to gain higher traction during the forecast period 2024-2030.

Report Coverage

The report: “Electric Motor Market Report– Forecast (2024-2030)”, by IndustryARC covers an in-depth analysis of the following segments of the Electric Motor market

By Product Type: AC Motor (Induction Motor, Synchronous Motor, Servo Motor, Stepper Motor), DC Motor (Brushed DC Motor, Brushless DC Motor, Servo Motor, Series Motor, Stepper motor, Compound Motor).

By Product Category: Permanent Magnet, Non-Permanent Magnet.

By Phase: Single Phase, Three Phase.

By Power Rating: Below 0.5W, 0.5W-1W, 1W to 100W, 100W to 1KW, 1KW to 10KW, 10KW and Above.

By Efficiency: IE1, IE2, IE3, IE4.

By Application: Commercial (Automated Doors, Elevators & Escalators, Blowers, Electric Sweepers, Hand Dryers, Data Center & UPS, Pumps, Power Tools, Water Coolers, Camera PTZ Control, Drones, Others), Consumer Products (Pumps, Hair Dryers, Lawn Mowers, Boilers, Dishwashers, Vacuum Cleaners, washing machine, Blenders & Mixers, Fans & Chimneys, Desktop & Laptops, Smartphones, Refrigerators, Others), Automotive (Body Control motors, EPS Motors, Brake Booster BLDC Motor, Seat Adjustment, Belt Tensioner, Car Window Motor, Door Lock Motors, Wiper Motor, Others), Medical & Healthcare (Diagnostic Equipment (CT Scanners, MRI, Biopsy Systems, Diagnostics Analyzers, Ultrasound Transducers, X-Ray, Others), Medical Centrifuges, Medical Pumps, Blowers and Compressors, Surgical Instruments (Saws, Drills, Surgical Robots, Others), Dental CAD/CAM Milling Machines, Exoskeleton & Prosthetics, Microscopes, Wheelchairs & Scooters, Stair Lifts, Hospital Beds & Exam Tables, Others).

By Geography: North America (U.S, Canada, Mexico), South America(Brazil, Argentina and others), Europe(Germany, UK, France, Italy, Spain, Russia, Netherlands, Poland, Czechia, Belgium, Sweden  and Others), APAC(China, Japan India, SK, Aus and Others), and RoW (Middle East and Africa)

Request Sample

Key Takeaways

• The rising demand for efficient energy usage over concerns of environmental impact of energy generation from conventional sources such as coal and natural gas, is expected to help grow the electric motor market in APAC.

• The DC Motor segment is growing at a significant CAGR of 7.6% in the forecast period 2024-2030. A DC motor consists of a stator and a rotor.

• Medical & Healthcare sector is expected to witness a highest CAGR of 8.5% the forecast period 2024-2030, due to its extensive reliance on electrically powered devices and equipment. Diagnostic imaging equipment, such as MRI and CT scanners, demands high-performance electric motors for precise movements and accurate imaging. 

• Electric Motor companies are strengthening their position through mergers & acquisitions and continuously investing in research and development (R&D) activities to come up with solutions to cater to the changing requirements of customers. 

Electric Motor Market Segment Analysis - By Product Type

The DC Motor segment is expected to grow at a significant CAGR of 7.6% during the forecast period 2024-2030. Owing to the growing penetration of brushless DC motors across various industry verticals substituting brushed dc and even ac induction motors in certain applications such as home appliances. DC motors are used in electric vehicles in the automotive industry for various non-traction applications, contributing to the ongoing shift towards sustainable transportation. As the demand for electric vehicles grows, so does the demand for efficient and dependable DC motors. DC motors are also widely used in industrial automation, powering conveyor systems, robotics, and manufacturing equipment. Owing to the ease of control, they are suitable for accurate and regulated movements in automated processes.

Inquiry Before Buying

Electric Motor Market Segment Analysis - By Application

Medical & Healthcare sector is expected to witness a highest growth of CAGR 8.5% during the forecast period 2024-2030, owing to the increase in investments in healthcare and medical sector, along with growing penetration of advanced medical devices & equipment in the sector such as surgical robots, advanced imaging & diagnostic equipment, prosthetics and so on. Medical advances and technical improvements have resulted in the development of a wide range of medical instruments and gear that significantly rely on the precision and efficiency provided by electric motors. High-performance electric motors are required for precise motions and accurate imaging in diagnostic imaging equipment such as MRI and CT scanners. Electric motors provide stability and consistency to patient care and monitoring systems such as infusion pumps and monitoring equipment. Furthermore, the incorporation of electric motors in mobility aids such as electric wheelchairs and patient lifts improves accessibility for people who have mobility issues. Electric motors are used in laboratory equipment, robotic surgical systems, and a variety of medical tools, all of which contribute to the overall efficiency and improvement of healthcare techniques. The demand for electric motors is on the rise as the healthcare industry evolves and adopts more technologically sophisticated solutions, fueling additional innovation in this critical sector.

Electric Motor Market Segment Analysis - By Geography 

Electric Motor market in Asia-Pacific region held significant market share of 38% in 2023. Increasing compliance for energy efficient motors and rising adoption of motor-driven electric vehicles are the key factors driving market growth.  The rising demand for efficient energy usage over concerns of environmental impact of energy generation from conventional sources such as coal and natural gas, is expected to help grow the electric motor market. In addition, advancements in the agriculture sector and enormous investments in industrialization in countries such as China, India, South Korea, and Australia is driving the market growth. Further, the increasing production and sales of electric vehicles in countries including China and Japan is also analyzed to drive the market growth. 

Schedule a Call

Electric Motor Market Drivers

Rise in demand for Electric Vehicles

The electric car market has witnessed rapid evolution with the ongoing developments in automotive sector and favorable government policies and support in terms of subsidies and grants, tax rebates. Major manufacturers such as General Motors, Toyota, and BMW plan to release a potential of 400 models and estimated global sales of 25 million by 2025. In 2022, Ford Motor has committed to increase its investments in electric vehicles to $50 billion by 2026, up from a previous spend of $30 billion by 2025. Similarly, in 2020, Volkswagen, Chinese ventures has committed to invest $17.5 billion in electric vehicles by 2025. As electric vehicles use various types of electric motors for traction & auxiliary applications, the rising demand for electric vehicles globally is set to assist the market growth for electric motors used in the same.

Growing R&D activities 

Manufacturers are continuously focusing on R&D to develop new and effective electric motors to meet consumer demand. Increasing concerns, such as environmental pollution and regulations, are forcing manufacturers to develop electric motors that reduce vibration and increase efficiency. For instance, a synchronous electric motor is around 80% more efficient than an induction electric motor. Similarly, the development of a new type of steel for electric motors, which reduces the weight of the electric motor and makes it more efficient and powerful. This new type of electric motor will be small in size and cost effective, which will raise demand from residential and commercial applications. Moreover growing developments from various companies is also analysed to drive the market growth. Hence these factors are analysed to drive the market growth in the forecast period 2024-2030.

Electric Motor Market Challenges 

Easy availability of low-quality electric motors

The market for electric motors is highly fragmented, with a significant number of domestic and international manufacturers. Product quality is a primary parameter for differentiation in this market. The organized sector in the market mainly targets industrial buyers and maintains excellent product quality, while the unorganized sector offers low-cost alternatives to tap local markets. Local manufacturers of electric motors in most countries target the unorganized sector and compete strongly with the global suppliers in the respective markets. Leading market players are currently exposed to intense competition from such unorganized players supplying inexpensive and low-quality electric motors. This acts as a key challenge for the growth of the market.

Buy Now

Market Landscape

Product launches, acquisitions, Partnerships and R&D activities are key strategies adopted by players in the Electric Motor market. Electric Motor top 10 companies include:

ABB Ltd

Johnson Electric Holdings Limited

Siemens AG

Rockwell Automation

Nidec Corporation

Bosch Electric

Regal Rexnord

Franklin Electric Company Inc.

Teco Electric & Machinery Co. Ltd.

Wolong Electric Group co. ltd.

Acquisitions/Product Launches

• In July 2023, Nidec Corporation announced that it has successfully developed a new electric power steering motor power pack*1 (“EPS-PP”).

• In July 2023, WEG announced new investments for its motor manufacturing plant located in Manaus, Brazil. The Company will invest R$ 48 million, in the next three years, to expand production capacity and adapt the plant to produce a new line of permanent magnet electric motors for split-type air conditioners

• In December 2023, Johnson Electric Launches 48-Volt Cooling Fan Module with High Power and Efficiency. Johnson Electric is pleased to announce the launch of the 48-Volt Cooling Fan Module with power up to 1.5kW to meet the most demanding cooling requirements.  The need to reduce emissions and increase the electrification of the vehicle, requires higher cooling performance and efficiency.